Description
Măriuca-Roxana GAVRILOAIA, Anton ALDEA, Raluca Maria SWOBODA, Roxana-Collete SANDULOVICI
The legislative era began in 1927, with the establishment FDA (Food and Drug Administration), and in 1962 they issued the first regulations regarding advertising medicines. Drug advertising in the 21st century is governed by directives, laws, regulations, guidelines and different codes of ethics in each country, but governed by the same principles. There are times when the pharmaceutical companies are facing a big dilemma and a lot of controversy when it comes to advertising medicines, and the fine line between advertising and pure information about medicines. Food supplements and medical devices are also subjected to debates within the advertising campaigns. Sales of over the counter (OTC) drugs and dietary supplements and medical devices have increased greatly in recent years, however, among consumers there is confusion between these range of products. In the EU countries the objective of advertising is dependent of the recipient (general public or healthcare provider). Advertising prescription medicines is strictly forbidden for the general public, but it is allowed under certain conditions for the OTC medicines. This study aims to review the regulation history and applications throughout the pharmaceutical sector taking as an example Romania’s case and the impact on the general publicthe main beneficiary of advertising.
Reviews
There are no reviews yet.